Shenzhen and Medical High-Tech Zone Partner as Four Projects Signed On Site

Great Wall Fund's Liang Furui: AI Drug Discovery Is One of the High-Value Application Directions in Pharma Worth Prioritizing

Zheshang Securities: Late October Earnings Season Intensifies, Three Opportunities in Oversold Tech, Strong Pharma, and Selective Consumer Segments

From Fundamental Catalysts to Technical Rebound: Is a New Round of Valuation Upgrade Coming for GenFleet Therapeutics-B (02595)?

GENFLEET-B (02595) Jumps Nearly 4% in Afternoon Trading; Oral KRAS G12D Inhibitor Discloses Strong Clinical Data

Abbisko-B (02256): Abbisko's Lavengratinib (ABSK061) for Achondroplasia Receives EMA Orphan Drug Designation

Edding Genor Pharma Repurchases 500,000 Shares for About HK$829,000

ALEBUND-B (09637) Plans H Share Buyback of Up to HK$100 Million

Biostar Pharma-B (02563) Announces First Patient Dosed in Phase III Trial of Utidelone Capsules for HER2-Negative Advanced Breast Cancer

Dizal Pharma Executives Sell Shares After $600M AstraZeneca Payment Lands, Raising Questions

ALEBUND-B Shares Surge Over 47% in Early Trading as AP308 Gains FDA Clinical Clearance and Domestic Acceptance

A-shares Fall for Four Straight Weeks, When Will They Stabilize? Flying Cars Ignite Hype, Capital Floods into General Aviation! Real Estate and Pharma Stage Big Rebound, the Truth About WuXi AppTec Emerges

AI Pullback, Healthcare Takes the Baton? Wall Street Is Already Playing It Out! Hong Kong Pharma Rebounds—Can the Rally Last?

Flying Cars Ignite Rally, General Aviation ETF Soars 6%; Real Estate Rebounds Sharply, Pharma Spikes Then Fades, WuXi AppTec Plummets Late Session — What Happened?

Humanwell Healthcare Compensation Claims Remain Open as Regulatory Investigation Continues

Bainuo Pharma's Second IPO Bid Fails as Self-Developed Transformation Model Faces Industry Downturn Test

Mainland China Stocks Open Sharply Higher as Pharma and Computing Hardware Shares Lead Gains

GENFLEET-B (02595) Surges Over 8% in Morning Session as Company Releases Multiple Clinical Results for KRAS G12D Inhibitor

Large-cap pharma stocks approach record highs as investors seek shelter from AI selloff

GenFleet-B Shares Rise Over 8% Intraday on Positive Progress in Multiple Domestic and Overseas Clinical Studies for GFH375/VS-7375